This retrospective observational cohort study aims to identify early predictors of short- and mid-term mortality in adult patients who achieved return of spontaneous circulation (ROSC) after cardiac arrest. Eligible patients admitted to the intensive care unit between January 1, 2024 and May 31, 2025 were identified retrospectively from electronic medical records following institutional ethics approval. Clinical, biochemical, and resuscitation-related parameters recorded within the first 24 hours of ICU admission were analyzed. The primary objective was to determine factors independently associated with short-term mortality. Six-month mortality was additionally assessed using hospital records and the national death registry. The findings are expected to improve risk stratification and clinical decision-making in post-cardiac arrest care.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years
* Achieved return of spontaneous circulation (ROSC) after cardiac arrest
* Admitted to the intensive care unit (ICU)
* Informed consent obtained from patient or legal representative (if applicable)
Exclusion Criteria:
* Age \< 18 years
* Known pregnancy
* Brain death at the time of ICU admission
* Patients with missing key clinical or laboratory data
* Declined participation or legal refusal
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial has already been completed and was focused on predicting 30-day mortality after cardiac arrest — does the data collected from this study change how my care team would assess my own risk or prognosis right now?
2Since this study looked at patients who had return of spontaneous circulation after cardiac arrest, including those with hypoxic-ischemic encephalopathy and coma, are any of the prediction tools or markers it studied already being used at this hospital to guide decisions about my treatment?
3Given that this was an observational study measuring mortality outcomes rather than testing a new treatment, are there any active clinical trials testing actual therapies for post-resuscitation syndrome or hypoxic-ischemic encephalopathy that might be worth considering for my situation?
4Could the findings from this completed study influence any specific decisions about my care in the ICU, such as how aggressively to continue treatment or when to reassess my neurological prognosis?
5Are the prediction models studied in this trial something my care team already relies on, or is this still considered emerging evidence that hasn't changed standard practice yet?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.